person

Micael W.

Country
Sweden
Department
Östersunds sjukhus, Kyrkgatan 12, 831 50 Östersund, Smittskyddsenheten

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 8 partner sites.

Specializations

Oncology

The investigator concentrates on targeted therapies for malignant neoplasms, emphasizing molecularly defined subtypes.

  • Advanced non‑small cell lung cancer with HER2 mutation
  • HPV‑related cervical intraepithelial neoplasia grades 2‑3 and cervical cancer
  • Severe asthma with an eosinophilic phenotype

Research aims to improve outcomes in patients with driver‑mutation–positive tumors and biologic‑driven airway disease.

Cardiovascular & Thrombotic Disorders

Focus is placed on antithrombotic strategies and vascular risk reduction across diverse cardiac conditions.

  • Atherosclerotic cardiovascular disease
  • Atrial fibrillation in chronic kidney disease stage 5
  • Prevention of ischemic stroke after non‑cardioembolic ischemic stroke or high‑risk TIA
  • Takotsubo syndrome
  • Acute myocardial infarction (NSTEMI and STEMI)

Therapeutic investigations target reduction of thrombo‑embolic events and major adverse cardiovascular outcomes.

Infectious Diseases & Immunology

Work includes antimicrobial stewardship and immune‑modulating approaches for severe infections.

  • Multidrug‑resistant urinary tract infections caused by ESBL‑producing Enterobacterales
  • Staphylococcus aureus bacteremia
  • COVID‑19 in patients with severely impaired B‑cell function
  • Urinary tract infection and bacteremia due to extended‑spectrum beta‑lactamase‑producing Enterobacterales

Efforts address optimal antimicrobial regimens and adjunctive immunoglobulin therapy.

Renal & Complement‑Mediated Disorders

Investigations target complement inhibition and renin‑axis modulation to preserve renal function.

  • C3 glomerulopathy
  • Diabetes mellitus type 1
  • Chronic kidney disease stage 5

Therapeutic focus includes direct renin inhibitors and complement‑blocking agents.

Respiratory & Gastrointestinal Health

Research spans functional disorders of the lower gastrointestinal tract and respiratory conditions.

  • Fecal incontinence due to external anal sphincter dysfunction
  • Hydrocele and spermatocele management
  • Induction of labour in outpatient settings

Clinical studies evaluate procedural safety and efficacy for these conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.